Sells everyday consumer goods across four main categories in India — Home Care, Foods, Beauty & Wellbeing, and Personal Care — through a network of more than 9 million retail outlets, with the Shikhar eB2B platform handling over one-third of sales. Home Care is the largest segment at Rs. 23,689 cr (37.5% of FY26 segment revenue), covering laundry, cleaning and dishwash products such as Vim Liquid and Dove. Foods contributed Rs. 14,061 cr (22.2%), spanning nutrition and staples including Horlicks Superfoods relaunched in South India. Beauty & Wellbeing generated Rs. 13,684 cr (21.6%), covering skin care, hair care and masstige brands such as Vaseline (which crossed Rs. 1,000 cr), Minimalist, OZiva, Simple and Nexus. Personal Care added Rs. 9,567 cr (15.1%). FY26 consolidated turnover was Rs. 63,763 cr with 5% underlying sales growth and a 24.15% EBITDA margin. Q1 FY27 sales grew 10%, led by Home Care at 14%. Materials are the largest cost line at 32.5% of revenue, currently hit by 8-10% inflation tied to Middle East supply disruption. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Home Care (38%), Foods (22%), Beauty & Wellbeing (22%), Personal Care (15%), Discontinued operations (2%), Others (includes Exports) (2%). Diversified, branded FMCG with volume-led growth and a portfolio premiumisation push
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 52,446 | 60,580 | 61,896 | 63,121 | 64,468 |
| EBITDA (ex other income) | 12,813 | 14,085 | 14,669 | 15,156 | 14,819 |
| margin % | 24.4 | 23.3 | 23.7 | 24.0 | 23.0 |
| Owners' profit | 8,879 | 10,120 | 10,277 | 10,649 | 15,040 |
| EPS, as reported (₹) | 37.79 | 43.07 | 43.74 | 45.32 | 64.01 |
| ROE % · ROCE % | 18.1 · 20.2 | 20.1 · 22.0 | 20.0 · 21.7 | 21.5 · 23.4 | 30.7 · 22.2 |
| Debt / equity (x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from operations | 9,048 | 9,991 | 15,469 | 11,886 | 10,999 |
| Capex | (1,225) | (1,174) | (1,468) | (1,254) | (1,258) |
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 15,926 | 15,818 | 15,670 | 16,514 | 16,241 | 16,441 | 16,351 | 17,341 |
| Profit before tax | 3,548 | 3,981 | 3,363 | 3,304 | 3,573 | 2,926 | 3,928 | 3,632 |
| Net profit | 2,595 | 2,989 | 2,475 | 2,768 | 2,694 | 6,603 | 2,994 | 2,680 |
| EPS (₹) | 11.03 | 12.70 | 10.48 | 11.73 | 11.43 | 28.12 | 12.73 | 11.38 |
| Segment | Revenue, ₹ crore | Share % |
|---|---|---|
| Home Care | 23,672 | 36.0 |
| Beauty & Wellbeing | 14,990 | 22.8 |
| Personal Care | 9,564 | 14.6 |
| Foods | 15,140 | 23.0 |
| Others (includes Exports) | 2,181 | 3.3 |
| Discontinued operations | 178 | 0.3 |
| Total, before eliminations | 65,725 | 100.0 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % |
|---|
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 11 Sept 2026 · HUL trading window closed for Q2 FY27, insiders barred till results | compliance | minimal | — | — |
| 9 Sept 2026 · HUL Investor Presentation at Barclays Conference: Strategy and Medium-Term Targets | investor communications | medium | — | — |
| 6 Sept 2026 · HUL Capital Markets Day 2026 video recording shared with investors | investor communications | medium | — | — |
| 4 Sept 2026 · HUL to participate in three investor conferences next week | board shareholder meetings | low | — | — |
| 4 Sept 2026 · HUL Capital Markets Day 2026: strategy for volume-led growth, 500 bps margin fuel | investor communications | medium | — | — |
| 4 Sept 2026 · HUL Capital Markets Day 2026: Winning in New India strategy outlined | investor communications | medium | — | — |
| 21 Aug 2026 · HUL notice on special window for re-lodging physical share transfers | compliance | minimal | — | — |
| 12 Aug 2026 · HUL to attend Motilal Oswal Global Investor Conference on 17 Aug | board shareholder meetings | low | — | — |
| 4 Aug 2026 · HUL Q1 FY27: 10% USG, highest in 13 quarters; EBITDA margin holds at 23% | investor communications | medium | — | — |
| 31 Jul 2026 · Newspaper publication of Q1 FY27 financial results | compliance | minimal | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| Rev CAGR 5y % |
|---|
| EBITDA m. % |
|---|
| HINDUSTAN UNILEVER LTD. ◆ | 4,52,845 | 30.3 | 9.24 | 28.9 | 30.7 | 21.5 | 6.5 | 23.4 |
| ITC LTD | 3,25,579 | 16.4 | 4.47 | 11.1 | 28.8 | 35.9 | 11.1 | 21.1 |
| HINDUSTAN FOODS LIMITED | 7,490 | 47.8 | 6.43 | 22.8 | 12.8 | 9.8 | 25.1 | 8.8 |
| GODAVARI BIOREFINERIES L | 1,198 | 7800.0 | 1.52 | 15.8 | 0.4 | 0.4 | — | 0.5 |
| RANA SUGARS LTD. | 226 | 39.7 | 0.38 | — | 4.0 | 4.9 | — | (1.7) |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 30.3 | 16.3 | 228 of 316 | 28% |
| P/B | 9.2 | 1.8 | 252 of 280 | 10% |
| ROCE | 21.5 | 7.5 | 45 of 335 | 87% |
| ROE | 30.7 | 7.3 | 20 of 294 | 94% |
| Debt / Equity | 0.0 | 0.3 | 11 of 294 | 81% |
| EBITDA margin | 23.4 | 8.3 | 41 of 272 | 85% |
| Revenue growth | 5.0 | 9.8 | 162 of 273 | 41% |
| Profit growth | (3.2) | 12.9 | 170 of 276 | 39% |
| Market cap | 452845 | 156 | 1 of 340 | 100% |
| A rating (BUY / ADD / REDUCE / SELL) |
| A state: the latest filed quarter and the measured reactions |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
